RankAlpha logo
Back to Rankings

MXCT

MaxCyteF
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-21
View Chart
+
Peers tracked
8
U.S. public peers
Grade Position
Below peers
vs peer average
MXCT vs peer average
36/100
MXCT vs. peer average (F vs. D)
Grade spread
B 2 · D 1 · F 5
Graded peers loaded
Coverage
8 graded
100% of tracked

Peer overview

AARD is the first available peer comparator.

Same sector: Pharmaceuticals, Biotechnology & Life Sciences · Cap $133.06M

✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
Top peerAARDAardvark Therapeutics
MXCT
MaxCyte
AARD
Aardvark Therapeutics
Grade
F
B
Momentum
19
88
Value
41
46
Sentiment
-
49
Setup Bias
Net —
-
Market Cap
-
-
Posture
Defensive
Constructive
Open Side-by-Side ComparisonCompare all

Grade position vs AARD

MXCT / AARD
Grade Position
Below peers
MXCT vs. peer average (F vs. D)
36/100
Momentum
19
AARD
Value
41
AARD
Sentiment
-
-

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs MXCT
1
AARD
Aardvark Therapeutics Inc Common
B
80/100
-3
2
PMN
ProMIS Neurosciences Inc Common
F
20/100
Even
3
VTVT
vTv Therapeutics Inc Class A Common
F
20/100
Even
4
GNLX
Genelux Corp Common
D
40/100
-1
5
ENGN
enGene Therapeutics Inc Common
B
80/100
-3
AARD is the first peer returned for this comparison set.